GlassScriptPhysician profile
Barbara D Sullivan
NPI 1912934126
$4,541.71
in general payments reported to CMS, 2019-2025
40 companies · $463 in 2025
The $463 reported for 2025 was more than what 79% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $334 · 2020: $515 · 2021: $1,303 · 2022: $680 · 2023: $837 · 2024: $411 · 2025: $463.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,711.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,710.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $979.01 | 2019-2023 | Lo Loestrin Fe, Liletta, Vraylar |
| Mayne Pharma Commercial LLC | $493.10 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $392.43 | 2023-2025 | Myfembree, Gemtesa |
| Intuitive Surgical, INC. | $330.00 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $301.32 | 2019-2024 | Trintellix |
| Amgen INC. | $208.00 | 2019-2022 | |
| Pfizer INC. | $176.64 | 2019-2025 | |
| Gynesonics, INC. | $141.05 | 2021 | |
| Shield Therapeutics INC | $140.58 | 2022-2024 | Accrufer |
| Hologic Sales and Service, LLC | $127.56 | 2023-2025 | Novasure, Myosure Tissue Removal Device |
| Coopersurgical, INC. | $107.46 | 2019-2021 | |
| Organon LLC | $107.22 | 2022-2025 | Jada System, Nexplanon |
| Sage Therapeutics, LLC | $96.20 | 2024-2025 | Zurzuvae |
| Exeltis, USA INC. | $77.46 | 2020-2025 | Slynd |
| Daiichi Sankyo INC. | $74.46 | 2019-2022 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Sullivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.